Vistin Pharma ASA: Invitation to Q2 2024 conference call

Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23 rdof August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 23 rdof August at 08:30 CET. There will be a Q&A session following the management discussion.The conference call will be held in English.The second quarter conference call will be available via web and audio through the following access points: Webcast: ...

Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23^rd of August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 23^rd of August at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The second quarter conference call will be available via web and audio through the following access points:

Webcast:
https://edge.media-server.com/mmc/p/v93s3oau

Telephone conference (online registration):
https://register.vevent.com/register/BIe6d25489e7ce45c18e8661e4d04d1d9a

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
[email protected]

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.